Port of Ningbo / Port of Qingdao / Port of Lianyungang
Pharmaceutical Intermediates CAS 162401-32-3 Roflumilast
1)Product Name:Pharmaceutical Intermediates CAS 162401-32-3 Roflumilast
2)Appearance:White crystalline powder
Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).
In June 2010, it was approved in the EU for severe COPD associated with chronic bronchitis. In March 2011, it gained FDA approval in the US for reducing COPD exacerbations.
Roflumilast has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such as asthma, and chronic obstructive pulmonary disease (COPD).
It is a selective phosphodiesterase 4 (PDE4) (IC50 = 0.8 nM) inhibitor. Inhibition of PDE4 prevents the hydrolysis of phosphodiesters, which play a key role in signal transduction. This compound has anti-inflammatory properties and is particularly effective at reducing inflammation in lung tissue.
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs. 2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
T/T,Wester Union,MoneyGram,L/C ,Trade Assurance etc.